Purpose: To describe the corticosteroid-sparing success in controlling chronic uveitis in
patients treated with TNFα inhibitors. Methods: Retrospective longitudinal case series of …

OBJECTIVE: To evaluate adalimumab therapy in refractory uveitis. DESIGN: Prospective
case series. PARTICIPANTS: A total of 131 patients with refractory uveitis and intolerance or …

Objective To establish the safety and efficacy of infliximab for the treatment of refractory
noninfectious uveitis. Design Retrospective, interventional, noncomparative cohort study …

Objective The aim of this study was to assess the efficacy of adalimumab in patients with
active non-infectious uveitis in three different centres. Methods In a retrospective study we …

Objective Infliximab, a monoclonal antibody against tumor necrosis factor α, is approved by
the US Food and Drug Administration for treatment of numerous autoimmune disorders. We …

Objective To analyze the factors associated with response to anti–tumor necrosis factor (anti‐
TNF) treatment and compare the efficacy and safety of infliximab (IFX) and adalimumab …

Purpose: The aim of this study was to assess the efficacy and safety of adalimumab in
treating refractory autoimmune uveitis. Methods: This work was a prospective …

PURPOSE: Anti–tumor necrosis factor α (anti–TNF-α) agents are being used increasingly in
refractory inflammatory eye diseases. We reviewed our patients on etanercept and infliximab …

Uveitis refers to the presence of intraocular inflammation, and as a strict definition
compromises the iris and ciliary body anteriorly and the choroid posteriorly (the uvea) …

Purpose: To evaluate the effectiveness and reasons for discontinuation including the side
effect profiles of adalimumab in a real-world setting. Design: A retrospective clinical cohort …